Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boosting That Bottom Line: Three Portfolio Pricing Tricks

Executive Summary

Increasing the price of your product constitutes one of the most direct ways to enhance profits, turning them into an effective means to improve the bottom line in the short term: Profit gains resulting from price increases are not only exempt from any additional costs, but they become almost immediately visible in a company’s financial reports. In this article, Karl-Hubertus Gruber and Michael Marquardt from Homburg & Partner reveal three techniques medtech companies can use to hike their profits.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel